Insider Transactions in Q2 2023 at Ideaya Biosciences, Inc. (IDYA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Jason Throne Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,553
-100.0%
|
$81,719
$23.02 P/Share
|
|
Jun 01
2023
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,553
+50.0%
|
$24,871
$7.01 P/Share
|
|
May 31
2023
|
Jason Throne Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
432
-100.0%
|
$9,936
$23.0 P/Share
|
|
May 31
2023
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
432
+50.0%
|
$3,024
$7.01 P/Share
|
|
May 22
2023
|
Jason Throne Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$11,500
$23.0 P/Share
|
|
May 22
2023
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$3,500
$7.01 P/Share
|
|
Apr 13
2023
|
Paul A. Stone Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+26.84%
|
$32,000
$4.62 P/Share
|
|
Apr 12
2023
|
Yujiro S Hata President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,601
+1.68%
|
$46,404
$4.31 P/Share
|